| Timi Davie, | |
|
3950 Grandview Dr, Simpsonville, SC 29680-3163 | |
| (864) 963-0272 | |
| (864) 963-2642 |
| Full Name | Timi Davie |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3950 Grandview Dr, Simpsonville, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588084180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12248 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Timi Davie, 3950 Grandview Dr, Simpsonville, SC 29680-3163 Ph: (864) 963-0272 | Timi Davie, 3950 Grandview Dr, Simpsonville, SC 29680-3163 Ph: (864) 963-0272 |
News Archive
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
In the face of a dramatic worldwide increase in adolescent obesity and Type 2 diabetes, The Forsyth Institute today announced a research alliance with the Dasman Diabetes Institute of Kuwait to initiate studies that could lay a scientific basis for prevention. This collaboration, called The Kuwait Healthy Life Study, will examine conditions in children that predispose them to obesity and Type 2 diabetes.
Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.
Members who choose one of Regence's consumer-directed health plans will soon benefit from a new banking relationship, now that the company has added HealthEquity as a banking partner.
› Verified 6 days ago
Dr. Angela Jeanine Godfrey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 618 Fairview Rd, Simpsonville, SC 29680 Phone: 864-962-1839 Fax: 864-962-1805 | |
Mr. Robert Thomas Cagle Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 698 Fairview Road, Simpsonville, SC 29680 Phone: 864-962-8991 Fax: 864-962-5094 | |
Megan Bouchard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Highway 14, Simpsonville, SC 29681 Phone: 864-757-7087 | |
Mary M Hess, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 124 Chessington Ln, Simpsonville, SC 29681 Phone: 864-616-9247 | |
Dr. Jennie Ann Parker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 Riverdale Rd, Simpsonville, SC 29680 Phone: 864-553-6125 | |
Kevin Michael Kelly, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 704 Fairview Rd, Simpsonville, SC 29680 Phone: 864-601-7010 | |
Mrs. Celeste Martin Vaughan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 114 Fox Trce, Simpsonville, SC 29680 Phone: 864-640-3200 |